Search for: "In the Matter of the Risk Level Determination of P. L." Results 61 - 80 of 297
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Dec 2013, 3:14 pm
  The idea here is that investor tastes will determine the viability of corporate behavior and states may signal approval or disapproval through mechanics of disclosure. [read post]
22 Jul 2016, 7:55 pm
Yet Raúl Castro did make a point of demanding the return of the Guantanamo base during President Obama's state visit to Cuba in March 2016 (e.g. here). [read post]
11 Oct 2023, 6:21 am
“Let us never forget, that also the ‘New Plural’ is just a pattern of cultural determinations which has no pretensions to endure beyond time and circumstance” (Broekman, supra, p. 197). [read post]
31 Jan 2022, 12:46 pm by Shannon O'Hare
Xi addressed the 1.4bn nation stating: “We must always keep a long-term perspective, remain mindful of potential risks, maintain strategic focus and determination, and attain the broad and great while addressing the delicate and minute”. [read post]
9 Feb 2015, 9:11 am
”  Courts give administrative agencies a lot of deference when it comes to subject matters within their purview. [read post]
I have found that the interpretation of the law, rather than the law itself, is what matters most in asylum cases.[2] It matters most because it determines the outcome of a case. [read post]
17 Jun 2022, 2:09 pm by admin
Of course, not only allergists try to determine the cause of an individual patient’s disease. [read post]
1 Jul 2019, 9:03 pm by Guest Contributor
This is intended to contribute to both higher levels of producer compliance as well as reductions in specific food safety risks. [read post]
8 May 2012, 5:58 pm by Andrew Cross
       P&L Center – A market participant maintains a separate profit and loss statement reflecting the results of swap activity or treating swap activity as a separate profit center; or   3. [read post]
8 Apr 2010, 9:48 am by Bexis
  But what the FDA can demand as a regulatory matter simply ain’t what the common-law requires. [read post]
18 May 2018, 3:56 am by Florian Mueller
As an initial matter, the risks faced by innovators are consistent with the "speculative investments" always made by technology and product developers; in contrast, implementers are vulnerable to paying supra-competitive royalties based on the entire value of the product, not on the value of the patented technology. [read post]
30 Aug 2015, 11:32 am by Schachtman
As the Circuit court saw the matter: “[T]his approach is not the stuff of science. [read post]
9 Aug 2019, 11:34 am by Rebecca Tushnet
Perhaps surprising: There’s no formal deference at PTO to int’l bodies and their naming of generics: WHO int’l nonproprietary names & US adopted names council. [read post]